Post-doctoral position : Species-specific mechanisms of ADAT dysfunction in cortical development (H/F)
A 30-month post-doctoral position is open at the Institute of Genetics and Molecular and Cellular Biology (IGBMC) in Strasbourg, France.
We are looking for a recently graduated PhD with experience in human iPSC-based 2D and 3D models and interest in translational control of neurodevelopment.
Reference
POST DOC - E.BAYAM
Contract type
POST-DOC
Publication date
08/20/2026
The recruited fellow will join the SpeaDAT project, funded by the French National Research Agency (ANR), on species-specific mechanisms of ADAT dysfunction in brain development, led by Dr. Efil Bayam (CRCN Inserm) within Dr. Juliette Godin's team “Physiological and Pathological Mechanisms of Cortical Development” (https://www.igbmc.fr/equipes/mecanismes-physiologiques-et-pathologique-du-developpement-cortical) at IGBMC. The Godin lab is recognized for its expertise in translational control during cortical development.
Chemical modifications on different types of RNA species have emerged as critical posttranscriptional modulators of brain development and function. While transfer RNAs (tRNA) are required for translation in all cells, 77% of the pathogenic mutations in transfer RNA (tRNA) modification enzymes manifest as neurodevelopmental disorders (NDDs) suggesting that developing human brain is particularly sensitive to disrupted tRNA modifications. Recently, the team identified the NDD-associated ADAT complex (ADAT2/3), which catalyzes the conversion of Adenine (A) to Inosine (I) at position 34 of 8 ANN-tRNAs, as a regulator of cortical development and showed the pathogenicity of NDD-relevant ADAT mutations.
Surprisingly, despite the profound impact of ADAT dysfunction in humans, mouse genetic models mimicking the ADAT dysfunction displayed no detectable brain phenotype or tRNA alterations suggesting species-specific vulnerability to defects in ADAT complex.
The postdoctoral researcher will investigate species-specific ADAT functions in progenitors and neurons, and characterize the impact of ADAT dysfunction on tRNAs and translational programs, using human iPSC- and mouse ESC- derived models, including 2D cortical neural stem cells/neurons and 3D cortical organoids carrying ADAT2/ADAT3 pathogenic variants.
Activities
- Generate and characterize human iPSC and mouse ESC-derived 2D cortical neural stem cells, neurons and 3D cortical organoids carrying ADAT2/ADAT3 pathogenic variants;
- Assess cellular phenotypes (proliferation, cell cycle dynamics, progenitor identity, neuronal maturation, synaptic integration) using immunofluorescence, EdU/pulse-chase labeling and functional assays (MEA, calcium imaging);
- Analyze and interpret human mim-tRNA-seq and ribosome profiling data to characterize species- specific tRNA and translational programs, in close collaboration with a bioinformatician;
- Present research findings at team and consortium meetings and at national/international conferences; contribute to manuscript writing, project reporting, and the supervision of students.
Technical skills
- PhD in Cell Biology, Molecular Biology, Developmental Biology, Neuroscience or a related field, recently obtained. - Experience with human iPSC culture and/or 2D/3D neural differentiation protocols is required as well as proficiency in standard molecular and cell biology techniques (immunofluorescence, western blot, qPCR, imaging).
- Familiarity with high-throughput sequencing approaches (RNA-seq, ribosome profiling) is a plus.
- Interest in neurodevelopment, neurodevelopmental disorders and translational control/epitranscriptomics. - Fast learner, autonomous, with strong organizational and communication skills (English, fluent, required), and the ability to work within an interdisciplinary, international consortium.
Further informations
- Work environment
IGBMC is a joint research unit of Inserm (U1258), CNRS (UMR7104) and the University of Strasbourg, located in Illkirch, Strasbourg. The institute benefits from an outstanding scientific environment with four departments dedicated to genetics, developmental and structural biology, and translational medicine.
The recruited fellow will join Dr. Juliette Godin's team within the Translational Medicine and Neurogenetics department working alongside Dr. Efil Bayam. The team currently comprises four permanent researchers, three postdoctoral researchers, one PhD student, three engineers and two technicians, offering a stimulating and international working environment. The fellow will have access to IGBMC's state-of-the-art technology platforms, including next-generation sequencing (GenomEast), advanced imaging (Imaging Center of IGBMC), proteomics.
- Salary and benefits
According to the Inserm salary scale for postdoctoral researchers based on experience (€2,940 brut / month for <2 years of experience); full health and social coverage included.
- Expected start / duration
As soon as possible / 30 months
- Relevant publications
- Del-Pozo-Rodriguez et al. ADAT3 variants disrupt the activity of the ADAT tRNA deaminase complex and impair neuronal migration. Brain (2025).
- Ramos-Morales et al. The structure of the mouse ADAT2/ADAT3 complex reveals the molecular basis for mammalian tRNA wobble adenosine-to-inosine deamination. Nucleic Acids Res 49, 6529-6548 (2021).
Application procedures
bayame@igbmc.fr / godin@igbmc.fr – Applicants must send a CV, a cover letter, and the names and contact details of at least two references to Dr. Efil Bayam (project coordinator) and Dr. Juliette Godin (Group Leader). Applications will be reviewed on a rolling basis. Deadline for application: 30/03/2027.
Related to :
- Research team(s) : Regulation of cortical development in health and disease